Interacting Drugs |
Basiliximab vs Natalizumab |
Security Level |
 |
Mechanism |
Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased. |
Management |
Avoid combination |
Basiliximab vs Natalizumab
Post Review about Basiliximab vs Natalizumab Click here to cancel reply.
Other Interactions of Basiliximab
Other Interactions of Natalizumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.